Identification and characterization of novel properties of the human D3 dopamine receptor

被引:30
|
作者
Kuzhikandathil, EV
Westrich, L
Bakhos, S
Pasuit, J
机构
[1] UMDNJ, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07103 USA
[2] UMDNJ, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA
关键词
D O I
10.1016/j.mcn.2004.01.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Among dopamine receptors, the function and properties of the D3 receptor subtype are poorly understood. Here we report the identification and characterization of two unique properties of the human D3 receptor. The D3 receptor exhibits a tolerance property wherein the magnitude of the second agonist-induced response is reduced by 60% compared to the first response and progressively decreases upon repeated agonist application. In addition, unlike the D2 dopamine receptor, the D3 receptor response terminates 15-fold more slowly upon agonist removal. Using D3/D2S chimeric receptors, we demonstrate that D3 receptor tolerance property is mediated by a novel conformational mechanism involving the D3 receptor second cytoplasmic region. The slow response termination rate property requires the third cytoplasmic region and is due to the high affinity of the D3 receptor for ligand as well as its unique G-protein signaling mechanism. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 155
页数:12
相关论文
共 50 条
  • [31] Characterization of the 5′ flanking region of the rat D3 dopamine receptor gene
    D'Souza, UM
    Wang, W
    Gao, DQ
    Kanda, S
    Lee, G
    Junn, E
    Hwang, CK
    Jose, PA
    Mouradian, MM
    JOURNAL OF NEUROCHEMISTRY, 2001, 76 (06) : 1736 - 1744
  • [32] Fused aminotetralins:: Novel antagonists with high selectivity for the dopamine D3 receptor
    Avenell, KY
    Boyfield, I
    Coldwell, MC
    Hadley, MS
    Healy, MAM
    Jeffrey, PM
    Johnson, CN
    Nash, DJ
    Riley, GJ
    Scott, EE
    Smith, SA
    Stacey, R
    Stemp, G
    Thewlis, KM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (20) : 2859 - 2864
  • [33] Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists
    Micheli, Fabrizio
    Cremonesi, Susanna
    Semeraro, Teresa
    Tarsi, Luca
    Tomelleri, Silvia
    Cavanni, Paolo
    Oliosi, Beatrice
    Perdona, Elisabetta
    Sava, Anna
    Zonzini, Laura
    Feriani, Aldo
    Braggio, Simone
    Heidbreder, Christian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (04) : 1329 - 1332
  • [34] Novel selective dopamine D3 receptor modulators for the treatment of cocaine addiction
    Chen, Peng-Jen
    Blass, Benjamin
    Gordon, John
    Luedtke, Robert
    Taylor, Michelle
    Korzekwa, Kenneth
    Ye, Min
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [35] A new twist to novel atypical antipsychotics:: Dopamine D3 receptor antagonism
    Drescher, K. U.
    Freeman, A. S.
    Wicke, K. M.
    Unger, L. V.
    Wernet, W.
    Haupt, A.
    Gross, G.
    Decker, M. W. .
    Schoemaker, H.
    Sullivan, J. P.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S4 - S4
  • [36] High-Throughput Screening for Novel Modulators of the D3 Dopamine Receptor
    Furman, Cheryse A.
    Free, R. Benjamin
    Roof, Rebecca A.
    Conroy, Jennie L.
    Titus, Steven A.
    Southall, Noel
    Sibley, David R.
    FASEB JOURNAL, 2011, 25
  • [37] Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist
    Moritz, Amy E.
    Free, R. Benjamin
    Weiner, Warren S.
    Akano, Emmanuel O.
    Gandhi, Disha
    Abramyan, Ara
    Keck, Thomas M.
    Ferrer, Marc
    Hu, Xin
    Southall, Noel
    Steiner, Joseph
    Aube, Jeffrey
    Shi, Lei
    Frankowski, Kevin J.
    Sibley, David R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (10) : 5526 - 5567
  • [38] In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease
    Simms, Sherise L.
    Huettner, Daniel P.
    Kortagere, Sandhya
    NEUROPHARMACOLOGY, 2016, 100 : 106 - 115
  • [39] In vivo Behavioral Characterization of ML417, a Novel D3 Dopamine Receptor-selective Agonist
    Akano, Emmanuel Oladele
    Moritz, Amy Elizabeth
    Preston, Michael Wayne
    Lobb, Collin Jethro
    Du Hoffmann, Johann Faustus
    Free, R. Benjamin
    Frankowski, Kevin J.
    Walters, Judith R.
    Sibley, David R.
    FASEB JOURNAL, 2018, 32 (01):
  • [40] Identification and characterization of a novel 5'UTR SNP in the human dopamine receptor D1 gene
    Shiina, T
    Rana, BK
    Ziegler, MG
    O'Connor, DT
    Insel, PA
    CIRCULATION, 2001, 104 (17) : 145 - 145